Correction: galectin-3 as a marker and potential therapeutic target in breast cancer.

Correction: galectin-3 as a marker and potential therapeutic target in breast cancer.

[This corrects the article DOI: 10.1371/journal.pone.0103482.].

Bibliographic Details
Main Author:	PLOS ONE Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4306549?pdf=render

Similar Items

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer.
by: Hao Zhang, et al.
Published: (2020-01-01)

Galectin-3 as a marker and potential therapeutic target in breast cancer.
by: Hao Zhang, et al.
Published: (2014-01-01)

Correction: Effective Therapeutic Approach for Head and Neck Cancer by an Engineered Minibody Targeting the EGFR Receptor.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: CD105 expression on CD34-negative spindle-shaped stromal cells of primary tumor is an unfavorable prognostic marker in early breast cancer patients.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Targeting and cytotoxicity of SapC-DOPS nanovesicles in pancreatic cancer.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: regulation of p53 level by UBE4B in breast cancer.
by: PLOS ONE Staff
Published: (2015-01-01)

Galectins—Potential Therapeutic Targets for Neurodegenerative Disorders
by: Sapana Chaudhary, et al.
Published: (2022-09-01)

Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
by: PLOS ONE Staff
Published: (2017-01-01)

Correction: Association of Genetic Markers in the BCL-2 Family of Apoptosis-Related Genes with Endometrial Cancer Risk in a Chinese Population.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells.
by: PLOS ONE Staff
Published: (2016-01-01)

Correction: Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.
by: PLOS ONE Staff
Published: (2018-01-01)

Correction: the impact of various platelet indices as prognostic markers of septic shock.
by: PLOS ONE Staff
Published: (2015-01-01)

Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target
by: Emily Capone, et al.
Published: (2021-09-01)

Correction: Attenuated Age-Impact on Systemic Inflammatory Markers in the Presence of a Metabolic Burden.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Genetic diversity of grasspea and its relative species revealed by SSR markers.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines.
by: PLOS ONE Staff
Published: (2020-01-01)

431 Galectin-3 as a Biomarker and Potential Therapeutic Target in Biliary Atresia
by: Dor Yoeli, et al.
Published: (2022-04-01)

Correction: hypoxia-ischemia and therapeutic hypothermia in the neonatal mouse brain-a longitudinal study.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Preoperative Axillary Staging with 3.0-T Breast MRI: Clinical Value of Diffusion Imaging and Apparent Diffusion Coefficient.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Novel and Stress Relevant EST Derived SSR Markers Developed and Validated in Peanut.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis.
by: PLOS ONE Staff
Published: (2016-01-01)

Galectin-3 as a Potential Target to Prevent Cancer Metastasis
by: Hafiz Ahmed, et al.
Published: (2015-01-01)

Galectin-3 as a Potential Target to Prevent Cancer Metastasis
by: Hafiz Ahmed, et al.
Published: (2015-11-01)

Correction: The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: In vitro sensitivity of Plasmodium falciparum from China-Myanmar border area to major ACT drugs and polymorphisms in potential target genes.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation.
by: PLOS ONE Staff
Published: (2016-01-01)

Correction: Vibrotactile information improves proprioceptive reaching target localization.
by: PLOS ONE Staff
Published: (2018-01-01)

Correction: Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Absence of Gamma-Interferon-Inducible Lysosomal Thiol Reductase (GILT) Is Associated with Poor Disease-Free Survival in Breast Cancer Patients.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Synergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence.
by: PLOS ONE Staff
Published: (2017-01-01)

Galectin-3 as a Potential Therapeutic Target in Tumors Arising from Malignant Endothelia
by: Kim D. Johnson, et al.
Published: (2007-08-01)

Correction: Mining CK2 in cancer.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: CRISPR Content Correlates with the Pathogenic Potential of Escherichia coli.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Quantitative in vivo mapping of myocardial mitochondrial membrane potential.
by: PLOS ONE Staff
Published: (2018-01-01)

Correction: Sagittal Abdominal Diameter as a Surrogate Marker of Insulin Resistance in an Admixtured Population-Brazilian Metabolic Syndrome Study (BRAMS).
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Dual-targeting of Arabidopsis DMP1 isoforms to the tonoplast and the plasma membrane.
by: PLOS ONE Staff
Published: (2017-01-01)